Myriad myPlan Lung Cancer measures the expression levels of specific genes along with pathological stage to predict the 5-year risk of lung adenocarcinoma death for stage I-II.
Myriad myPlan Lung Cancer measures the expression levels of specific genes along with pathological stage to predict the 5-year risk of lung adenocarcinoma death for stage I-II.
Myriad myPlan Lung Cancer measures the expression levels of specific genes along with pathological stage to predict the 5-year risk of lung adenocarcinoma death for stage I-II.
Myriad myPlan Lung Cancer measures the expression levels of specific genes along with pathological stage to predict the 5-year risk of lung adenocarcinoma death for stage I-II.